Cargando…
NMPA-approved traditional Chinese medicine-Pingwei Pill: new indication for colistin recovery against MCR-positive bacteria infection
BACKGROUND: The wide spread of plasmid-mediated colistin resistance by mobile colistin resistance (MCR) in Enterobacteriaceae severely limits the clinical application of colistin as a last-line drug against bacterial infection. The identification of colistin potentiator from natural plants or their...
Autores principales: | Sheng, Qiushuang, Du, Runbao, Ma, Cunhui, Zhou, Yonglin, Shen, Xue, Hou, Xiaoning, Xu, Lei, Li, Li, Deng, Xuming, Wang, Jianfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524834/ https://www.ncbi.nlm.nih.gov/pubmed/34663394 http://dx.doi.org/10.1186/s13020-021-00518-y |
Ejemplares similares
-
Novel targeted drugs approved by the NMPA and FDA in 2019
por: Wang, Wenjing, et al.
Publicado: (2020) -
In Vitro/Vivo Activity of Potential MCR-1 Inhibitor in Combination With Colistin Againsts mcr-1-Positive Klebsiella pneumonia
por: Zhou, Yonglin, et al.
Publicado: (2018) -
Pogostone Enhances the Antibacterial Activity of Colistin against MCR-1-Positive Bacteria by Inhibiting the Biological Function of MCR-1
por: Xie, Shengnan, et al.
Publicado: (2022) -
The Application of Cinnamon Twig Extract as an Inhibitor of Listeriolysin O against Listeria monocytogenes Infection
por: Hou, Xiaoning, et al.
Publicado: (2023) -
Value assessment of NMPA-approved new cancer drugs for solid cancer in China, 2016–2020
por: Luo, Jing, et al.
Publicado: (2023)